Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2
Xia Rao(Chinese Academy of Sciences), Feng Gao(Minnan Normal University), Yan Wu(Chinese Academy of Sciences), Shuxin Guo(University of Macau), Pu Han(Chinese Academy of Sciences), Zhou Tong(Beijing Normal University), Weiwei Zou(Capital Medical University), Peng Jia(Shenyang University of Technology), Qihui Wang(Shanxi Agricultural University), Dedong Li(Insmed (United States)), Kefang Liu(Wenzhou Medical University), Weiyu Peng(Chinese Academy of Sciences), Jianyu Tong(Shanxi Academy of Building Research), Lianpan Dai(Chinese Academy of Sciences), Weiwei Li(Yancheng Institute of Technology), Zhaohui Li(Chinese Academy of Sciences), Xue Zhang(Hebei Medical University), Rong Zhang(Washington University in St. Louis), Shihua Li(Fuzhou University), Xin Zhao(Chinese Academy of Sciences), Lili Wu(Chinese Academy of Sciences), Feiran Wang(Shanghai University), George F. Gao(Chinese Academy of Sciences), Runchu Zhao(Chinese Academy of Sciences), Yan Chai(Chinese Academy of Sciences)
Cited by 35
Related Papers
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
|Trends in Microbiology|2016|3.1k
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.3k
Correction: Corrigendum: The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes
|Scientific Reports|2016|2.1k
Viral targets for vaccines against COVID-19
|Nature reviews. Immunology|2020|1.1k